Search

Paper: Phage-like particle vaccines are highly immunogenic and protect against pathogenic coronavirus infection and disease.

Daniela Staquicini (Rutgers Cancer Institute of New Jersey) and colleagues published a new paper in PNAS on the design and proof of concept of two phage-based, cold-free COVID-19 vaccination strategies. They show that aerosol vaccination wi

Jingen Zhu (The Catholic University of America, Washington, DC) and colleagues published a new preprint describing the use of CRISPR-engineered phage T4 as a universal platform to produce vaccines against SARS-CoV-2. They found high levels

Adaptive Phage Therapeutics (APT) is working toward a phage-based COVID vaccine — a phage engineered to express epitopes of SARS-CoV2 on the surface of the capsid. Phage-based vaccines are attractive because they are considered safe in the

Alejandro González-Mora (Tecnologico de Monterrey, Mexico) and colleagues published a new review in Vaccines on phage-based vaccines for antigen delivery.